A study involving Columbia researchers finds that malaria parasites in Africa have developed resistance to artemisinin drugs, which could worsen malaria’s impact if partner drugs fail in the future.
The way SARS-CoV-2 mutates in immunocompromised patients to escape Paxlovid could help chemists design better drugs that are more difficult for the virus to sidestep.
Columbia researchers have found why babies are susceptible to repeated bouts of common respiratory infections—but also have a unique weapon to fight off new pathogens that healthy adults lack.
Mailman researchers estimate that the overall COVID-19 fatality rate in New York City is 1.45%, twice that of estimates from other countries, and older adults have the greatest mortality risk.
COVID-19 patients positioned in a facedown, prone position while awake and supplied with supplemental oxygen were less likely to need a ventilator, Columbia University researchers have found.
A type of ultraviolet light called far-UVC—which is safe to use around people—kills more than 99.9% of airborne coronaviruses, a new study at Columbia has found.
During the height of the COVID-19 pandemic in New York City, health care workers on the front lines had high levels of acute stress, anxiety, and depression.
In "Understanding Coronavirus," Columbia's Raul Rabadan provides answers to the most common questions surrounding the new coronavirus for a general audience.
A new dashboard developed by public health scientists at Columbia University highlights age, race/ethnicity, and sex disparities in COVID-19 cases state by state.
A new study reveals how P. aeruginosa bacteria—which cause many deaths worldwide from pneumonia—commandeer our immune defenses to thrive inside the lungs.
A study of nearly 400 pregnant women is among the first to show that socioeconomic status and household crowding increase the risk of getting COVID-19.